ACTUATE THERAPEUTICS’ PROGRAMS HIGHLIGHTED IN CLINICAL CANCER RESEARCH

CHICAGO, IL and FORT WORTH, TX, April 3, 2017 – Actuate Therapeutics, Inc., a Chicagobased biopharmaceutical company, today announced that an article authored by its scientific founders titled “Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer” was published on March 31, 2017 in the Molecular Pathways special feature in […]

ACTUATE THERAPEUTICS’ PROGRAMS HIGHLIGHTED IN CLINICAL CANCER RESEARCH Read More »